New drugs for treating dyslipidemia: beyond statins - Test2 - elhamkhani - TriplyDB

New drugs for treating dyslipidemia: beyond statins

New drugs for treating dyslipidemia: beyond statins

http://www.wikidata.org/entity/Q26821840

about

Cellular Model of Atherogenesis Based on Pluripotent Vascular Wall Pericytes Retargeting the management of hypercholesterolemia - focus on evolocumab Role of growth hormone-releasing hormone in dyslipidemia associated with experimental type 1 diabetes Pre-treatment with simvastatin prevents the induction of diet-induced atherosclerosis in a rabbit model.Emerging biologic therapies for hypercholesterolaemia.The Potential Therapeutic Application of Peptides and Peptidomimetics in Cardiovascular Disease.ANMCO/ISS/AMD/ANCE/ARCA/FADOI/GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/SID/SIF/SIMEU/SIMG/SIMI/SISA Joint Consensus Document on cholesterol and cardiovascular risk: diagnostic-therapeutic pathway in Italy.Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment.2017 Position Paper of the Italian Society for Cardiovascular Prevention (SIPREC) for an Updated Clinical Management of Hypercholesterolemia and Cardiovascular Risk: Executive Document.Sobetirome: the past, present and questions about the future.Host-targeting therapies for hepatitis C virus infection: current developments and future applications.

P2860

Q26765860-F44C0BA6-1D7E-447B-B6BC-11279B534374 Q28077289-D2D0AB86-88CF-4A62-80E7-DD583C76253E Q36607551-42356CA1-E881-4F54-B7D7-7C91E4B8177C Q37581629-BDF7B79C-2AEB-451B-A287-2ABFF9176BC6 Q38724666-45821850-07BD-4434-A851-72A0C5BEBB0A Q38767234-67651315-9722-466D-8740-490D15E1F4F3 Q40104818-688301BE-EB4C-47C6-9A42-F6426CFE5B7F Q47557757-5EEEA5D7-06FB-4ED4-BA47-B48298CEB471 Q48123127-203BE818-A380-4E51-896A-376DB0FB2CF9 Q48321308-02A8D6D3-CC31-492F-966C-2F165ADB8D71 Q55280981-54DAEF0C-9CBC-4C34-8561-AA84FE2D0CF5

P2860

New drugs for treating dyslipidemia: beyond statins

http://www.wikidata.org/entity/Q26821840

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

New drugs for treating dyslipidemia: beyond statins

@ast

New drugs for treating dyslipidemia: beyond statins

@en

New drugs for treating dyslipidemia: beyond statins

@nl

type

label

New drugs for treating dyslipidemia: beyond statins

@ast

New drugs for treating dyslipidemia: beyond statins

@en

New drugs for treating dyslipidemia: beyond statins

@nl

prefLabel

New drugs for treating dyslipidemia: beyond statins

@ast

New drugs for treating dyslipidemia: beyond statins

@en

New drugs for treating dyslipidemia: beyond statins

@nl

P1433

Q26821840-4DC3942A-DC14-49C2-8DA8-3CE7DEB865F7

P1476

Q26821840-599A7AEF-523E-461B-B539-B43A80892F05

P2093

Q26821840-BF49C980-9E68-4944-B73D-52BC6B700F92

Q26821840-C61CBECB-C620-4FBC-B1B7-143EFF5F1CA2

P2860

Q26821840-0403EE5F-3010-4555-B418-7853BF89D335

Q26821840-0925C1CE-874E-4935-BC0F-10A5497C5711

Q26821840-0EC9E274-737D-4A1D-98EE-2CEBCCD50566

Q26821840-13ADBCBC-944D-4949-8532-138F5ABF8D56

Q26821840-2380030B-791F-474A-AF3C-CEA0BD05B849

Q26821840-268C243E-503E-4A35-B9C7-4E309A7E33AF

Q26821840-30207FC1-B1CA-4878-BDFF-83EF2F5FBDC6

Q26821840-3D0C3771-9EF7-4000-A5BF-3D95B0D2442D

Q26821840-3F0E28CD-2DAB-4E64-BF6F-634289A9F6FB

Q26821840-50C08E93-BF1C-47A2-AE81-1849FA86FB40

P304

Q26821840-637767DB-4AF3-4117-8826-8B3F67AE5726

P31

Q26821840-929175F9-3B65-4DBF-B0A6-F2DB3542F124

P3181

Q26821840-63BE7E4B-E211-4949-AF9D-467516A8A343

P356

Q26821840-19D10ED9-15FE-4A67-AD5F-3E474E9891A0

P407

Q26821840-B89E5163-301A-45D1-8604-B024DFC2561B

P433

Q26821840-24CAD282-F722-41BC-902F-F275C2CC43FB

P478

Q26821840-725BCA46-03BC-4412-B8D4-099E1262898F

P577

Q26821840-D11473FB-AD1D-493B-B917-172823DB1A22

P5875

Q26821840-A016E4DE-90FE-47BF-BE5D-C338E298E8F4

P698

Q26821840-58D71724-76BF-4970-8FFE-4D7FAA8B389F

P921

Q26821840-06A10459-BD4A-4EF2-A57C-ED600C3921E0

P932

Q26821840-8C62DE53-7570-4802-A31D-EB89B3B98924

P3181

P356

DMJ.2015.39.2.87

P1433

Diabetes & metabolism journal

P1476

New drugs for treating dyslipidemia: beyond statins

@en

P2093

Chang Ho Ahn

http://www.w3.org/2001/XMLSchema#string

Sung Hee Choi

http://www.w3.org/2001/XMLSchema#string

P2860

Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia

A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family

AIMilano apoprotein identification of the complete kindred and evidence of a dominant genetic transmission

Molecular biology of PCSK9: its role in LDL metabolism

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia

Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol levels in statin-intolerant patients: the GAUSS randomized trial.

Lomitapide and mipomersen: two first-in-class drugs for reducing low-density lipoprotein cholesterol in patients with homozygous familial hypercholesterolemia.

Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.

P304

87-94

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3654522

http://www.w3.org/2001/XMLSchema#string

P356

10.4093/DMJ.2015.39.2.87

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275661367

http://www.w3.org/2001/XMLSchema#string

P698

25922802

http://www.w3.org/2001/XMLSchema#string

P921

P932

4411552

http://www.w3.org/2001/XMLSchema#string